Katarina Vulic, B.Sc.
katarina.vulic@utoronto.ca
Project Bio
One of the goals of the Shoichet group is to develop injectable drug delivery strategies for treatment of compressive spinal cord injury (SCI). Our approach to injectable drug delivery is minimally invasive, seeking to deliver a variety of neuroprotective and neuroregenerative agents in a localized and controlled manner. Our strategy is based on drug loaded hydrogels injected into the intrathecal space, immediately adjacent to the spinal cord.
Previous work in the Shoichet group has found the biopolymer blend of hyaluronan and methylcellulose (HAMC) optimal for short term delivery of therapeutic agents to the intrathecal space. I am currently investigating methods of chemical modification that would allow for the controlled release of growth factors over a 7-10 day period.
Employment and Education
September 2004 - May 2008
BSc. in Biopharmaceutical Science, Medicinal Chemistry option
Department of Chemistry, University of Ottawa
Thesis Supervisor: Dr. William W. Ogilvie
May - August 2007, 2006, 2005
Undergraduate Research Scholar/NSERC USRA Scholar
Department of Chemistry, University of Ottawa
Supervisor: Dr. William W. Ogilvie
Undergraduate Research Scholar
Department of Biochemistry, Microbiology and Immunology, University of Ottawa
Supervisor: Dr. Illimar Altosaar
Awards
NSERC PGS-M Scholarship
